Science Deferred Long Term Liab vs Long Term Debt Analysis

SAIC Stock

USD 111.66 0.40 0.36%

Science Applications financial indicator trend analysis is much more than just breaking down Science Applications prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Science Applications is a good investment. Please check the relationship between Science Applications Deferred Long Term Liab and its Long Term Debt accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Science Applications International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Deferred Long Term Liab vs Long Term Debt

Deferred Long Term Liab vs Long Term Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Science Applications Deferred Long Term Liab account and Long Term Debt. At this time, the significance of the direction appears to have strong relationship.

The correlation between Science Applications' Deferred Long Term Liab and Long Term Debt is 0.7. Overlapping area represents the amount of variation of Deferred Long Term Liab that can explain the historical movement of Long Term Debt in the same time period over historical financial statements of Science Applications International, assuming nothing else is changed. The correlation between historical values of Science Applications' Deferred Long Term Liab and Long Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Deferred Long Term Liab of Science Applications International are associated (or correlated) with its Long Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Debt has no effect on the direction of Deferred Long Term Liab i.e., Science Applications' Deferred Long Term Liab and Long Term Debt go up and down completely randomly.

Correlation Coefficient

0.7

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Long Term Debt

Long-term debt is a debt that Science Applications has held for over one year. Long-term debt appears on Science Applications International balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Science Applications International balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Most indicators from Science Applications' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Science Applications current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Science Applications International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

At present, Science Applications' Enterprise Value Over EBITDA is projected to drop based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 13.87, whereas Selling General Administrative is forecasted to decline to about 234.2 M.

	2021	2022	2023	2024 (projected)
Interest Expense	105M	120M	138M	86.4M
Depreciation And Amortization	165M	157M	142M	110.4M

Interest Expense Depreciation And Amortization

Science Applications fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets
Common Stock Shares Outstanding		0.58	0.14	0.58	0.82	0.67	0.62	0.77	-0.38	0.83	0.36	0.91	0.02	0.25	0.91	0.94	0.1	0.08	0.27	-0.15	-0.31	0.49	0.51	0.97	0.4	-0.35
Total Assets	0.58		0.86	0.61	0.79	0.95	0.94	0.52	0.51	0.79	0.49	0.45	0.82	0.02	0.45	0.77	0.85	0.82	0.11	0.42	0.4	0.98	0.91	0.65	0.4	0.55
Short Long Term Debt Total	0.14	0.86		0.26	0.46	0.7	0.78	0.31	0.84	0.42	0.54	0.08	0.93	-0.15	0.08	0.4	0.92	0.99	-0.01	0.59	0.64	0.92	0.77	0.25	0.21	0.85
Other Current Liab	0.58	0.61	0.26		0.84	0.64	0.55	0.16	-0.06	0.63	-0.26	0.53	0.33	0.13	0.53	0.65	0.39	0.16	0.33	0.04	0.03	0.55	0.51	0.61	0.76	0.07
Total Current Liabilities	0.82	0.79	0.46	0.84		0.76	0.78	0.61	-0.04	0.77	0.27	0.82	0.36	0.12	0.82	0.91	0.42	0.35	0.3	0.05	-0.02	0.76	0.7	0.89	0.77	0.04
Total Stockholder Equity	0.67	0.95	0.7	0.64	0.76		0.88	0.49	0.35	0.87	0.41	0.48	0.72	0.11	0.48	0.82	0.78	0.68	0.13	0.3	0.31	0.87	0.87	0.69	0.29	0.41
Property Plant And Equipment Net	0.62	0.94	0.78	0.55	0.78	0.88		0.66	0.42	0.76	0.5	0.49	0.73	-0.08	0.49	0.76	0.75	0.75	0.13	0.36	0.32	0.93	0.94	0.66	0.38	0.46
Current Deferred Revenue	0.77	0.52	0.31	0.16	0.61	0.49	0.66		-0.12	0.64	0.65	0.73	0.11	0.05	0.73	0.73	0.14	0.29	0.07	0.11	-0.32	0.52	0.59	0.76	0.21	-0.17
Net Debt	-0.38	0.51	0.84	-0.06	-0.04	0.35	0.42	-0.12		0.02	0.29	-0.46	0.89	-0.28	-0.46	-0.12	0.85	0.88	-0.11	0.62	0.74	0.58	0.48	-0.29	-0.12	0.99
Retained Earnings	0.83	0.79	0.42	0.63	0.77	0.87	0.76	0.64	0.02		0.29	0.6	0.42	0.32	0.6	0.83	0.51	0.4	-0.05	0.34	-0.15	0.7	0.77	0.77	0.32	0.05
Accounts Payable	0.36	0.49	0.54	-0.26	0.27	0.41	0.5	0.65	0.29	0.29		0.39	0.32	-0.08	0.39	0.49	0.31	0.56	0.02	0.05	0.23	0.51	0.45	0.44	-0.12	0.21
Cash	0.91	0.45	0.08	0.53	0.82	0.48	0.49	0.73	-0.46	0.6	0.39		-0.12	0.19	1.0	0.88	-0.06	-0.01	0.31	-0.27	-0.32	0.42	0.37	0.96	0.58	-0.42
Non Current Assets Total	0.02	0.82	0.93	0.33	0.36	0.72	0.73	0.11	0.89	0.42	0.32	-0.12		-0.17	-0.12	0.28	0.99	0.94	-0.02	0.62	0.67	0.84	0.77	0.1	0.12	0.92
Non Currrent Assets Other	0.25	0.02	-0.15	0.13	0.12	0.11	-0.08	0.05	-0.28	0.32	-0.08	0.19	-0.17		0.19	0.17	-0.12	-0.19	-0.47	0.18	-0.31	-0.03	0.05	0.21	0.15	-0.26
Cash And Short Term Investments	0.91	0.45	0.08	0.53	0.82	0.48	0.49	0.73	-0.46	0.6	0.39	1.0	-0.12	0.19		0.88	-0.06	-0.01	0.31	-0.27	-0.32	0.42	0.37	0.96	0.58	-0.42
Net Receivables	0.94	0.77	0.4	0.65	0.91	0.82	0.76	0.73	-0.12	0.83	0.49	0.88	0.28	0.17	0.88		0.34	0.33	0.32	-0.09	-0.04	0.7	0.66	0.98	0.49	-0.08
Good Will	0.1	0.85	0.92	0.39	0.42	0.78	0.75	0.14	0.85	0.51	0.31	-0.06	0.99	-0.12	-0.06	0.34		0.93	-0.01	0.61	0.61	0.85	0.8	0.16	0.14	0.88
Non Current Liabilities Total	0.08	0.82	0.99	0.16	0.35	0.68	0.75	0.29	0.88	0.4	0.56	-0.01	0.94	-0.19	-0.01	0.33	0.93		-0.02	0.61	0.65	0.87	0.75	0.17	0.06	0.88
Inventory	0.27	0.11	-0.01	0.33	0.3	0.13	0.13	0.07	-0.11	-0.05	0.02	0.31	-0.02	-0.47	0.31	0.32	-0.01	-0.02		-0.63	0.12	0.1	-0.12	0.3	0.16	-0.08
Other Current Assets	-0.15	0.42	0.59	0.04	0.05	0.3	0.36	0.11	0.62	0.34	0.05	-0.27	0.62	0.18	-0.27	-0.09	0.61	0.61	-0.63		0.16	0.48	0.52	-0.15	0.04	0.61
Other Stockholder Equity	-0.31	0.4	0.64	0.03	-0.02	0.31	0.32	-0.32	0.74	-0.15	0.23	-0.32	0.67	-0.31	-0.32	-0.04	0.61	0.65	0.12	0.16		0.44	0.25	-0.19	-0.06	0.78
Total Liab	0.49	0.98	0.92	0.55	0.76	0.87	0.93	0.52	0.58	0.7	0.51	0.42	0.84	-0.03	0.42	0.7	0.85	0.87	0.1	0.48	0.44		0.89	0.59	0.45	0.61
Property Plant And Equipment Gross	0.51	0.91	0.77	0.51	0.7	0.87	0.94	0.59	0.48	0.77	0.45	0.37	0.77	0.05	0.37	0.66	0.8	0.75	-0.12	0.52	0.25	0.89		0.55	0.34	0.51
Total Current Assets	0.97	0.65	0.25	0.61	0.89	0.69	0.66	0.76	-0.29	0.77	0.44	0.96	0.1	0.21	0.96	0.98	0.16	0.17	0.3	-0.15	-0.19	0.59	0.55		0.53	-0.25
Short Term Debt	0.4	0.4	0.21	0.76	0.77	0.29	0.38	0.21	-0.12	0.32	-0.12	0.58	0.12	0.15	0.58	0.49	0.14	0.06	0.16	0.04	-0.06	0.45	0.34	0.53		-0.03
Intangible Assets	-0.35	0.55	0.85	0.07	0.04	0.41	0.46	-0.17	0.99	0.05	0.21	-0.42	0.92	-0.26	-0.42	-0.08	0.88	0.88	-0.08	0.61	0.78	0.61	0.51	-0.25	-0.03

Click cells to compare fundamentals

Science Applications Account Relationship Matchups

Science Applications fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	59M	58.7M	58.1M	55.8M	53.7M	101.4M
Total Assets	4.7B	5.7B	5.7B	5.5B	5.3B	4.7B
Short Long Term Debt Total	2.1B	2.7B	2.7B	2.5B	2.2B	1.9B
Other Current Liab	203M	690M	592M	471M	514M	387.7M
Total Current Liabilities	1.1B	1.3B	1.4B	1.1B	1.2B	950.5M
Total Stockholder Equity	1.4B	1.5B	1.6B	1.7B	1.8B	1.4B
Property Plant And Equipment Net	281M	344M	309M	250M	243M	225.2M
Current Deferred Revenue	41M	82M	55M	48M	43.2M	51.9M
Net Debt	1.9B	2.5B	2.6B	2.4B	2.2B	1.4B
Retained Earnings	506M	627M	818M	1.0B	1.4B	1.5B
Accounts Payable	814M	517M	612M	624M	567M	459.8M
Cash	188M	171M	106M	109M	94M	89.3M
Non Current Assets Total	3.3B	4.4B	4.5B	4.3B	4.2B	2.8B
Non Currrent Assets Other	(153M)	(192M)	129M	(243M)	167M	175.4M
Cash And Short Term Investments	188M	171M	106M	109M	94M	89.3M
Net Receivables	1.1B	962M	1.0B	936M	914M	864.1M
Good Will	2.1B	2.8B	2.9B	2.9B	2.9B	1.9B
Liabilities And Stockholders Equity	4.7B	5.7B	5.7B	5.5B	5.3B	4.7B
Non Current Liabilities Total	2.2B	2.9B	2.8B	2.7B	2.4B	1.9B
Inventory	146M	143M	156M	142M	3M	2.9M
Other Current Assets	25M	19M	78M	81M	120M	126M
Other Stockholder Equity	984M	1.0B	838M	637M	337M	513.7M
Total Liab	3.3B	4.2B	4.1B	3.8B	3.5B	3.3B
Property Plant And Equipment Gross	281M	344M	309M	250M	427M	239.6M
Total Current Assets	1.4B	1.3B	1.3B	1.2B	1.1B	1.4B
Accumulated Other Comprehensive Income	(72M)	(89M)	(37M)	22M	16M	16.8M
Short Term Debt	70M	68M	148M	31M	77M	65.4M
Intangible Assets	711M	1.1B	1.1B	1.0B	894M	540.0M
Other Liab	102M	133M	244M	203M	233.5M	245.1M
Other Assets	100M	123M	138M	129M	148.4M	155.8M
Long Term Debt	1.9B	2.4B	2.4B	2.3B	2.0B	1.4B
Property Plant Equipment	91M	344M	309M	92M	105.8M	119.9M
Net Tangible Assets	(1.3B)	(2.4B)	(2.4B)	(2.1B)	(1.9B)	(2.0B)
Retained Earnings Total Equity	506M	627M	818M	1.0B	1.2B	1.2B
Long Term Debt Total	1.9B	2.4B	2.4B	2.3B	2.7B	1.7B
Capital Surpluse	983M	1.0B	838M	637M	732.6M	670.1M
Non Current Liabilities Other	133M	244M	160M	218M	174M	118.3M
Common Stock	1.5B	1.4B	1.6B	1.7B	1.9B	2.0B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

When determining whether Science Applications offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Science Applications' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Science Applications International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Science Applications International Stock:

How To Invest In Science

Details

Is Science Stock a good investment?

Details

What is Science Applications' Net Worth?

Details

Largest IT Consulting & Other Services Companies

View

Largest Information Technology Services Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Science Applications International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Is IT Consulting & Other Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Science Applications. If investors know Science will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Science Applications listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.65)

Earnings Share

5.94

Revenue Per Share

140.869

Quarterly Revenue Growth

0.019

Return On Assets

0.0583

The market value of Science Applications is measured differently than its book value, which is the value of Science that is recorded on the company's balance sheet. Investors also form their own opinion of Science Applications' value that differs from its market value or its book value, called intrinsic value, which is Science Applications' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Science Applications' market value can be influenced by many factors that don't directly affect Science Applications' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Science Applications' value and its price as these two are different measures arrived at by different means. Investors typically determine if Science Applications is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Science Applications' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Science Deferred Long Term Liab vs Long Term Debt Analysis

Deferred Long Term Liab vs Long Term Debt

Deferred Long Term Liab vs Long Term Debt Correlation Analysis

Correlation Coefficient

Deferred Long Term Liab

Long Term Debt

Science Applications fundamental ratios Correlations

Science Applications Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Science Applications fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Non Current Liabilities Total	+ 0.99	Short Long Term Debt Total
Intangible Assets	+ 0.99	Net Debt
Good Will	+ 0.99	Non Current Assets Total
Total Liab	+ 0.98	Total Assets
Total Current Assets	+ 0.98	Net Receivables

Other Current Assets	- 0.63	Inventory
Inventory	- 0.47	Non Currrent Assets Other
Cash And Short Term Investments	- 0.46	Net Debt
Cash	- 0.46	Net Debt
Intangible Assets	- 0.42	Cash And Short Term Investments
Intangible Assets	- 0.42	Cash